NEW YORK, March 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

HIV Therapy Patent Landscape 2009

http://www.reportlinker.com/p0180099/HIV-Therapy-Patent-Landscape-2009.html

IP Overview presents a patent landscape analysis of the HIV Therapy field.

Discovered in 1983, the HIV virus has been the subject of intensive research and development within the academic and industrial sectors. With the perspective of a global market of 10 billion US$, applicants filed more than 6800 patents and patent applications.

Protease and Reverse Transcriptase Inhibitors were the first therapies to be investigated and still are the major therapies on the market. Entry and Integrase inhibitors were then investigated since 1995 and are now the major therapeutics under clinical development.

Despite the huge increase in HIV market and the needs for new therapies, multiple signals are showing that HIV research and development is running short of new thematic and is practically collapsing since 2005 with a 40% drop in the number of patent applications. This paradox hides multiple scenarios with former leaders becoming followers and new companies emerging on specific or yet unexplored segments. In the same times, new collaborations are forming changing drastically acquired positions between established players.

After 25 years of successes and drawbacks in the treatment of HIV, this IP Overview provides you with a comprehensive panorama of the intellectual property landscape and helps you:

- Position your company's R&D and IP Portfolio

- Identify key inventors and key players involved in specific thematic and/or therapeutic target

- Understand the collaboration networks and theirs dynamics

- Uncover trends and emerging segments

METHODOLOGY 8

INTRODUCTION 9

1 BRIEF OUTLINE OF THE MARKET 12

2 A BRIEF OUTLINE OF THE PIPELINE 14

3 PROTECTION STRATEGIES 15

3.1 Evolution of patent filings 15

3.2 Priority patent applications 16

3.3 Extensions 18

3.4 Analysis of industrial patents over time 19

3.5 Study of the granting of US patents 20

3.6 Study of the granting of European patents 22

3.7 Evolution of the number of applicants 23

4 TOPOLOGY OF PATENTS IN THE SECTOR 25

4.1 Breakdown of patents into therapeutic targets 25

4.2 Breakdown of patents by application 27

4.3 Cross-analysis of the categories "applications" and "therapeutic targets" 30

4.4 Breakdown of patents by class of compounds 31

4.5 Cross-analysis of the categories "class of compound" and "therapeutic

target" 33

4.6 Cross-analysis of the categories "class of compound" and "application" 34

4.7 Breakdown of the main IPC codes of patents 35

5 APPLICANTS 37

5.1 Analysis for the entire period (1983-2006) 37

5.1.1 Main applicants (1983-2006) 37

5.1.2 Collaborations (1983-2006) 38

5.1.3 Topics protected (1983-2006) 41

5.2 Analysis for the pioneer period (1983-1992) 45

5.2.1 Pioneer applicants (1983-1992) 45

5.2.2 Collaborations from 1983-1992 46

5.2.3 Topics protected (1983-1992) 49

5.3 Analysis for the intermediary period (1993-2000) 53

5.3.1 Main applicants (1993-2000) 53

5.3.2 Collaborations (1993-2000) 54

5.3.3 Topics protected (1993-2000) 57

5.4 Analysis for the most recent period (2001 - 2006) 61

5.4.1 Major applicants (2001-2006) 61

5.4.2 Collaborations (2001-2006) 63

5.4.3 Protected topics (2001-2006) 65

6 INVENTORS IN THE FIELD 69

6.1 Inventors for the entire period (1983-2006) 69

6.1.1 The main inventors 69

6.1.2 The experts 71

6.1.3 Mobility of inventors 71

6.1.4 Research teams for the entire period (1983-2006) 73

6.1.5 Topics 74

6.1.6 Description of the main inventors 77

6.2 Pioneer inventors (1983-1992) 79

6.3 Main inventors from 1993 to 2000 85

6.4 Main inventors from 2001 to 2006 92

6.5 Emerging inventors 99

7 CONCLUSION 100

7.1 No novel therapies in sight 100

7.2 Repositioning of the major industrial players 101

7.3 Market players to redefine their strategies 103

To order this report:

Pharmaceutical Industry: HIV Therapy Patent Landscape 2009

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

Back to top